Related Experiment Video
Updated: Aug 6, 2025

Retrograde Perfusion and Filling of Mouse Coronary Vasculature as Preparation for Micro Computed Tomography Imaging
Published on: February 10, 2012
Invasive Intracoronary Imaging of Cardiac Allograft Vasculopathy: Established Modalities and Emerging Technologies
Negeen Shahandeh1, Rushi V Parikh2
1Division of Cardiology, University of California, 100 Medical Plaza, Suite 630 East, Los Angeles, CA 90095, USA.
Insights
Cardiac allograft vasculopathy (CAV) hinders long-term heart transplant survival. Emerging intracoronary imaging offers earlier detection and insights compared to coronary angiography, but requires further validation.
Area of Science:
- Cardiology
- Transplant Medicine
- Medical Imaging
Background:
- Cardiac allograft vasculopathy (CAV) remains a significant challenge for heart transplant recipients despite decades of medical advances.
- Early detection and management of CAV are critical for improving patient survival and long-term transplant success.
Purpose of the Study:
- To highlight the limitations of current diagnostic methods for CAV.
- To introduce and discuss the potential of novel intracoronary imaging modalities for earlier CAV detection and mechanistic understanding.
- To emphasize the need for validation studies of these emerging technologies.
Main Methods:
- Review of current literature on CAV diagnosis and management.
- Discussion of intracoronary imaging techniques (e.g., intravascular ultrasound, optical coherence tomography) in the context of CAV.
- Analysis of the sensitivity and specificity of different imaging modalities.
Main Results:
- Coronary angiography, the standard for CAV screening, demonstrates limited sensitivity in detecting early-stage disease.
- Intracoronary imaging modalities offer enhanced vessel analysis and plaque characterization, facilitating earlier CAV identification.
- These advanced techniques provide deeper insights into the mechanisms underlying CAV development post-transplant.
Conclusions:
- Novel intracoronary imaging techniques show promise for improving the early diagnosis of cardiac allograft vasculopathy.
- Further research and validation are essential before widespread clinical adoption of these advanced imaging platforms in heart transplant recipients.
Abstract:
Despite advances in the care of heart transplant recipients during the past 5 decades, cardiac allograft vasculopathy (CAV) continues to be a major barrier to long-term survival. The early diagnosis and treatment of CAV is crucial for improving long-term outcomes. Coronary angiography, the current gold standard for CAV screening, has low sensitivity for detecting early CAV. Increasingly, invasive intracoronary imaging modalities that provide a more detailed analysis of vessel anatomy and allow for plaque characterization are being used to detect CAV earlier after transplant and uncover mechanistic insights. Studies validating these emerging imaging platforms are needed before their widespread adoption.
More Related Videos
06:39Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 18, 2020
13:16Computed Tomography and Optical Imaging of Osteogenesis-angiogenesis Coupling to Assess Integration of Cranial Bone Autografts and Allografts
Published on: December 22, 2015
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies
Cardiac Catheterization I: Pre-Procedure Overview
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies VII: Vascular Imaging